FGL2 knockout in glioma cells did not affect the proliferation of tumour cells in immunocompromised mice but completely impaired glioblastoma progression in immune‐competent mice, suggesting that FGL2 has an important role in regulation of the immune environment in glioblastoma.28 Here, FGL2 is linked to central nervous system cancer.